IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LAGANÀ, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.725
AS - Asia 2.126
EU - Europa 1.710
SA - Sud America 329
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 44
OC - Oceania 4
Totale 8.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.595
SG - Singapore 797
IT - Italia 553
CN - Cina 478
BD - Bangladesh 259
BR - Brasile 258
PL - Polonia 250
FI - Finlandia 200
HK - Hong Kong 189
VN - Vietnam 171
DE - Germania 167
GB - Regno Unito 110
CA - Canada 73
FR - Francia 73
IE - Irlanda 62
TR - Turchia 60
RU - Federazione Russa 59
UA - Ucraina 59
IN - India 45
SE - Svezia 35
NL - Olanda 32
ID - Indonesia 26
MX - Messico 26
AR - Argentina 23
CZ - Repubblica Ceca 18
BE - Belgio 17
ZA - Sudafrica 17
JP - Giappone 16
ES - Italia 15
EC - Ecuador 14
IQ - Iraq 14
AT - Austria 10
CH - Svizzera 10
PH - Filippine 10
CO - Colombia 9
PK - Pakistan 9
DZ - Algeria 8
CL - Cile 7
CR - Costa Rica 7
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 7
HN - Honduras 6
JM - Giamaica 6
PT - Portogallo 6
UZ - Uzbekistan 6
VE - Venezuela 6
BG - Bulgaria 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
EE - Estonia 4
LB - Libano 4
RO - Romania 4
TH - Thailandia 4
AU - Australia 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
LC - Santa Lucia 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 7.939
Salva come PNG Salva come JPEG
Città #
Singapore 432
Ashburn 385
San Jose 361
Dallas 250
Warsaw 246
Hong Kong 189
Council Bluffs 154
New York 149
Helsinki 148
Los Angeles 132
Fairfield 121
Beijing 115
Chandler 92
Chicago 81
The Dalles 79
Munich 62
Milan 61
Santa Clara 56
Seattle 55
Ho Chi Minh City 54
Brescia 53
Wilmington 53
Columbus 51
Houston 48
Istanbul 46
Lauterbourg 46
Princeton 45
Buffalo 44
Woodbridge 43
Boardman 39
Dalmine 39
Jacksonville 39
Cambridge 38
Turku 35
Redondo Beach 30
Rome 30
Secaucus 30
Shanghai 30
Hanoi 29
Dublin 28
San Francisco 27
Moscow 26
Jakarta 25
Salt Lake City 25
Dong Ket 24
Orem 24
Naples 23
Menlo Park 22
Phoenix 22
São Paulo 22
London 21
Atlanta 20
Nuremberg 20
West Jordan 20
Bergamo 19
Des Moines 19
Poplar 18
Toronto 18
Ann Arbor 16
Elk Grove Village 16
Lappeenranta 16
Stockholm 16
Boston 15
Brno 15
Brooklyn 15
Montreal 15
Brussels 14
Rio de Janeiro 14
Johannesburg 13
Frankfurt am Main 12
Tampa 12
Amsterdam 11
Romola 11
Tokyo 11
Denver 10
Manchester 10
Pune 10
Turin 10
Las Vegas 9
San Diego 9
Biên Hòa 8
Charlotte 8
Chennai 8
Da Nang 8
Paris 8
Tianjin 8
Bari 7
Brasília 7
Curitiba 7
Dulles 7
Düsseldorf 7
Miami 7
New Delhi 7
Sterling 7
Ankara 6
Dearborn 6
Dhaka 6
Guangzhou 6
Livorno 6
Mumbai 6
Totale 4.833
Salva come PNG Salva come JPEG
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 389
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 267
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 234
Immunotherapy failure in adrenocortical cancer: where next? 229
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 207
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 207
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 192
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 191
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 179
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 170
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 166
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 158
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 154
Oncological treatment administration at end of life: a retrospective study 152
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 148
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 142
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 141
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 140
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 138
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 137
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 137
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 135
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 134
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 131
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 129
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 128
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 127
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 125
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 124
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 122
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 121
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 119
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 118
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 118
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 117
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 115
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 112
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 111
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 105
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 105
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 98
Adjuvant denosumab for early breast cancer-Evidence and controversy 95
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 94
The Evolving Treatment Landscape of Medullary Thyroid Cancer 93
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 90
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 89
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 88
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 87
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 86
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 82
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 79
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 78
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 68
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 62
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 61
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 58
Oligometastatic adrenocortical carcinoma: definition and treatment 58
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 57
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 52
null 51
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 51
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 49
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 47
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 45
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 45
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 41
Primary Adrenal Malignancies 22
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 22
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma 16
Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report 15
Updating ACC preclinical models: characterization of two new patient-derived cell lines 14
Antineoplastic effect of block-and-replace strategy for managing hypercortisolism caused by adrenal cortical carcinoma 1
Environmental pollution is associated with poorer survival in patients with adrenocortical carcinoma: findings from a national cohort study in Italy 1
Circulating tumor cells predict early skeletal-related events in patients with bone metastases from breast cancer 1
Totale 8.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.796
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 0 0 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20263.760 238 361 376 349 305 247 475 177 265 356 329 282
2026/2027833 159 149 211 314 0 0 0 0 0 0 0 0
Totale 8.070